Sponsor:
Orlando Health, Inc.
Code:
NCT06340620
Conditions
Pancreatic Disease
Pancreatic Cancer
Pancreatic Cyst
Gastrointestinal Tumor
Bile Duct Diseases
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Endoscopic ultrasound examination
Brief summary:
Conditions
Pancreatic Disease
Pancreatic Cancer
Pancreatic Cyst
Gastrointestinal Tumor
Bile Duct Diseases
Study ID
NCT06340620
Start date
Mar 25, 2024
Status verified date
Mar, 2024
Completion date
Dec, 2027
Anticipated
Primary completion date
Dec, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
140 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Diagnostic
Arms
active comparator: Standard echoendoscope
active comparator: EndoSound Vision System
Interventions
Endoscopic ultrasound examination
Primary outcome measure
Central contacts
Locations
Orlando Health
Recruiting
Orlando, Florida, United States, 32806
Contacts
Sponsor
Orlando Health, Inc.
Last update posted
Apr 1, 2024
Last verified
Mar, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Orlando Health, Inc. on 2024-04-01.